Literature DB >> 15475263

Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis.

Revati Koratkar1, Karen A Silverman, Ed Pequignot, Walter W Hauck, Arthur M Buchberg, Linda D Siracusa.   

Abstract

Genetic background affects polyp development in the Multiple intestinal neoplasia (Apc(Min)) mouse model. The Modifier of Min 1 (Mom1) locus accounts for approximately 50% of the variation in polyp multiplicity. We generated reciprocal congenic lines, such that the recipient C57BL/6J (B6) strain carries a donor C3H/HeJ (C3H) Mom1 allele, and the recipient C3H strain carries a donor B6 Mom1 allele. Hybrid progeny from congenic females mated to B6 Apc(Min/+) males were analyzed. A single C3H Mom1 locus on the B6 background reduced small intestinal polyp numbers by 50% and colon polyp incidence by 66% compared to their susceptible B6 Mom1(S/S)Apc(Min/+) siblings. These findings show that the C3H genome contains a resistant Mom1(R) locus. The reciprocal congenic line, which carries the susceptible B6 Mom1(S) locus on the C3H background, reduced small intestinal polyp numbers by 80% and colon polyp incidence by 95% compared to B6 Mom1(S/S)Apc(Min/+) mice. These data demonstrate that unidentified modifiers in the C3H strain can suppress intestinal polyp multiplicity in Apc(Min/+) mice, and act in the absence of a resistant Mom1(R) locus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475263     DOI: 10.1016/j.ygeno.2004.07.010

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to Apc Min/+ tumorigenesis.

Authors:  Marina Markova; Revati A Koratkar; Karen A Silverman; Vincent E Sollars; Melina MacPhee-Pellini; Rhonda Walters; Juan P Palazzo; Arthur M Buchberg; Linda D Siracusa; Steven A Farber
Journal:  Oncogene       Date:  2005-09-22       Impact factor: 9.867

2.  Identification of five novel modifier loci of Apc(Min) harbored in the BXH14 recombinant inbred strain.

Authors:  Stephanie C Nnadi; Rayneisha Watson; Julie Innocent; Gregory E Gonye; Arthur M Buchberg; Linda D Siracusa
Journal:  Carcinogenesis       Date:  2012-05-24       Impact factor: 4.944

3.  The armadillo repeat domain of Apc suppresses intestinal tumorigenesis.

Authors:  Richard C Crist; Jacquelyn J Roth; Amy A Baran; Benjamin J McEntee; Linda D Siracusa; Arthur M Buchberg
Journal:  Mamm Genome       Date:  2010-10-01       Impact factor: 2.957

4.  The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression.

Authors:  Amy A Baran; Karen A Silverman; Joseph Zeskand; Revati Koratkar; Ashley Palmer; Kristen McCullen; Walter J Curran; Tina Bocker Edmonston; Linda D Siracusa; Arthur M Buchberg
Journal:  Genome Res       Date:  2007-03-26       Impact factor: 9.043

Review 5.  APC and its modifiers in colon cancer.

Authors:  Lawrence N Kwong; William F Dove
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

6.  Helicobacter hepaticus infection promotes colon tumorigenesis in the BALB/c-Rag2(-/-) Apc(Min/+) mouse.

Authors:  Claude M Nagamine; Jane J Sohn; Barry H Rickman; Arlin B Rogers; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

7.  Mouse models for colorectal cancer.

Authors:  Baktiar O Karim; David L Huso
Journal:  Am J Cancer Res       Date:  2013-06-20       Impact factor: 6.166

8.  Genetic background influences murine prostate gene expression: implications for cancer phenotypes.

Authors:  Daniella Bianchi-Frias; Colin Pritchard; Brigham H Mecham; Ilsa M Coleman; Peter S Nelson
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.